Document Detail

Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.
MedLine Citation:
PMID:  10893069     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Hyperhomocysteinemia is a factor that predisposes to thrombosis, and the C677T mutation in methylene-tetrahydrofolate reductase (MTHFR) is known to give increased plasma homocysteine. We wanted to investigate if these factors were overrepresented in a group of patients with central retinal vein occlusion. METHODS: 116 patients with a history of central retinal vein occlusion were examined for the presence of hyperhomocysteinemia and the MTHFR C677T mutation. RESULTS: Compared to the control groups, there was no significant increase, neither in plasma homocysteine nor in the frequency of the MTHFR C677T mutation in the patients. Even when we looked selectively at the young patients, age less than 50 years, no difference could be detected. CONCLUSION: It seems that neither hyperhomocysteinemia nor the MTHFR C677T mutation is an important risk factor for the aetiology of central retinal vein occlusion.
J Larsson; B Hultberg; A Hillarp
Related Documents :
20935309 - Assessing chloroquine toxicity in ra patients using retinal nerve fibre layer thickness...
18235909 - Thrombophilic mutations and risk of retinal vein occlusion.
1344749 - Retinal periphlebitis and retinal pigment epithelium changes associated with multiple s...
16876509 - Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial h...
21071739 - Cone structure in retinal degeneration associated with mutations in the peripherin/rds ...
8065699 - Photic maculopathy resulting from the light of a video camera in patients taking triazo...
8937349 - The cyp2d6b allele is not overrepresented in a population of german patients with idiop...
2702459 - Intraperitoneal rupture of amoebic liver abscess.
6823639 - Primary sclerosing cholangitis associated with inflammatory bowel disease in cape town,...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta ophthalmologica Scandinavica     Volume:  78     ISSN:  1395-3907     ISO Abbreviation:  Acta Ophthalmol Scand     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-10-18     Completed Date:  2000-11-07     Revised Date:  2008-03-17    
Medline Journal Info:
Nlm Unique ID:  9507578     Medline TA:  Acta Ophthalmol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  340-3     Citation Subset:  IM    
Department of Ophthalmology, Lund University Hospital, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
DNA / analysis*
Electrophoresis, Polyacrylamide Gel
Gene Frequency
Genetic Markers
Hyperhomocysteinemia / enzymology,  genetics*
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Oxidoreductases Acting on CH-NH Group Donors / blood,  genetics*
Point Mutation*
Retinal Vein Occlusion / enzymology,  etiology,  genetics*
Risk Factors
Reg. No./Substance:
0/Genetic Markers; 9007-49-2/DNA; EC 1.5.-/Oxidoreductases Acting on CH-NH Group Donors; EC Reductase (NADPH2)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cataract surgery and effectiveness. 1. Variation in costs between different providers of cataract su...
Next Document:  Immunolocalization of transforming growth factor-beta1 and tenascin in human secondary cataract.